1.
Matsumoto Y, Fukumoto T, Takahashi W, Nishigori C. Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma. Dermatol Reports [Internet]. 2022 Dec. 29 [cited 2024 Nov. 24];15(2). Available from: https://www.pagepress.org/journals/dr/article/view/9617